Search results
Results from the WOW.Com Content Network
A potentially controversial method of producing biopharmaceuticals involves transgenic organisms, particularly plants and animals that have been genetically modified to produce drugs. This production is a significant risk for its investor due to production failure or scrutiny from regulatory bodies based on perceived risks and ethical issues.
Pages in category "Biopharmaceuticals" The following 21 pages are in this category, out of 21 total. This list may not reflect recent changes. ...
AbbVie Inc. is an American pharmaceutical company headquartered in North Chicago, Illinois.It is ranked sixth on the list of largest biomedical companies by revenue.In 2023, the company's seat in Forbes Global 2000 was 74, [2] and rank 89 on the 2024 list. [3]
Chiron's vaccines and blood testing units were combined to form Novartis Vaccines and Diagnostics, while Chiron BioPharmaceuticals was integrated into Novartis Pharmaceuticals. In 2014, Novartis completed the sale of its blood transfusion diagnostics unit to Grifols and announced agreements for the sale of its vaccines unit to GlaxoSmithKline .
Image source: Getty Images. 1. AbbVie. AbbVie (NYSE: ABBV) is recognized as a global leader in biopharmaceuticals. The company's portfolio spans multiple therapeutic areas, including its strong ...
The Food and Drug Administration issued a warning about the dangers of using unauthorized versions of fat-dissolving injections, saying it has received reports of severe side effects, such as ...
Lundbeck Seattle Biopharmaceuticals is a pharmaceutical development company based in Bothell, Washington. Formerly known as Alder Biopharmaceuticals, it specializes in therapeutic monoclonal antibodies. In May 2014, Alder went public. [1] In early 2018, the company made a public stock offering, aiming to raise US$250 million. [2]
Main page; Contents; Current events; Random article; About Wikipedia; Contact us; Pages for logged out editors learn more